Transurethral resection of the prostate: still the gold standard?
Ramsey
E W
EW
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000736:Androstenes / Q000627:therapeutic use; D001378:Azasteroids / Q000627:therapeutic use; D002404:Catheterization; D018120:Finasteride; D006801:Humans; D006979:Hyperthermia, Induced; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011224:Prazosin / Q000031:analogs & derivatives / Q000627:therapeutic use; D011468:Prostatectomy / Q000401:mortality; D011470:Prostatic Hyperplasia / Q000453:epidemiology / Q000401:mortality / Q000628:therapy*
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D000736:Androstenes; D001378:Azasteroids; D018120:Finasteride; C041226:Terazosin; D011224:Prazosin